DexCom
DXCM
730 hedge funds and large institutions have $33.1B invested in DexCom in 2021 Q1 according to their latest regulatory filings, with 91 funds opening new positions, 294 increasing their positions, 232 reducing their positions, and 87 closing their positions.
27% more repeat investments, than reductions
Existing positions increased: 294 | Existing positions reduced: 232
2.22% more ownership
Funds ownership: 378.92% → 381.14% (+2.2%)
5% more first-time investments, than exits
New positions opened: 91 | Existing positions closed: 87
1% less funds holding
Funds holding: 734 → 730 (-4)
2% less capital invested
Capital invested by funds: $33.6B → $33.1B (-$509M)
12% less call options, than puts
Call options by funds: $464M | Put options by funds: $526M
14% less funds holding in top 10
Funds holding in top 10: 7 → 6 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Janus Henderson Group
London,
|
+$469M |
| 2 |
Sands Capital Management
Arlington,
Virginia
|
+$242M |
| 3 |
UBS AM
Chicago,
Illinois
|
+$182M |
| 4 |
Artisan Partners
Milwaukee,
Wisconsin
|
+$169M |
| 5 |
Capital Research Global Investors
Los Angeles,
California
|
+$148M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$609M |
| 2 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$285M |
| 3 |
Morgan Stanley
New York
|
-$268M |
| 4 |
Jennison Associates
New York
|
-$109M |
| 5 |
JP Morgan Chase
New York
|
-$71.6M |
DXCM Hedge Fund Activity: Q1 2021 in Review
730 of the 5,711 institutional investors tracked by Wall St. Rank reported a position in DexCom (DXCM) for Q1 2021, worth a combined $33.1B — down 1.5% from $33.6B a quarter earlier.
Buyers outnumbered sellers: 91 funds opened new DXCM positions and 87 closed out — a net gain of 4 holders — while 294 added to existing stakes and 232 trimmed.
The largest buyer was Janus Henderson Group, adding an estimated $469M. The largest seller was Fidelity Investments, cutting an estimated $609M.
- 730 institutional investors held DexCom (DXCM) as of Q1 2021, down from 734 in Q4 2020.
- Funds reported $33.1B of DexCom stock for Q1 2021, down 1.5% quarter-over-quarter.
- 91 funds opened new DexCom positions in Q1 2021 and 87 closed out, a net change of +4 holders.
- The largest DexCom buyer in Q1 2021 was Janus Henderson Group, an estimated $469M added.
- The largest DexCom seller in Q1 2021 was Fidelity Investments, an estimated $609M sold.
Based on aggregated 13F filings for Q1 2021.